- Adjusted operating income increased 32% year-over-year, marking the fourth consecutive quarter of year-over-year growth.
- Alternative investment returns were 10% annualized or $101 million, supporting earnings.
- Annuities generated operating income of $287 million, slightly down from $297 million in prior year quarter, driven by traditional variable annuity outflows offset by growth in spread income.
- Estimated RBC ratio remained above 420%, well above the 400% target.
- Group Protection delivered record earnings of $173 million, up 33% year-over-year, with margin increasing 250 basis points to 12.5%.
- Life Insurance reported operating earnings of $32 million, a significant improvement from an operating loss of $35 million in the prior year quarter.
- Net income available to common stockholders was $688 million or $3.80 per diluted share.
- Retirement Plan Services operating earnings were $37 million, down from $40 million year-over-year but up sequentially from $34 million.
- Second quarter adjusted operating income available to common stockholders was $427 million or $2.36 per diluted share.
Explore Similar Insights
- Ameris Bancorp reported net income of $109.8 million or $1.60 per diluted share in Q2, a 21% increase year-over-year.
- Capital ratios strengthened with common equity Tier 1 at 13% and tangible common equity (TCE) ratio at 11.09%.
- Deposits increased slightly by $20 million, with noninterest-bearing deposits growing to 31% of total deposits.
- Loan growth was 6.5% annualized, driven mostly by commercial and industrial (C&I) loans, with total loan production at $1.9 billion.
- Provision for credit losses was $2.8 million, with asset quality improving across nonperforming assets, net charge-offs, and classified loans.
- Return on assets (ROA) improved to 1.65%, return on tangible common equity (ROTE) rose to 15.8%, and the efficiency ratio improved to 51.63%.
- Revenue grew at an annualized rate of 20.9%, outpacing expense growth, with net interest margin (NIM) expanding 4 basis points to 3.77%.
- Capital ratios increased: CET1 at 10.2%, TCE at 8.06%, both up year-over-year and sequentially.
- Commercial & Industrial (C&I) loans grew over $700 million year-to-date, driving loan growth.
- Efficiency ratio improved to below 56%, the lowest since early 2023.
- Net interest income (NII) reached a record $300 million, up 17% year-over-year.
- Net interest margin (NIM) expanded to 3.04%, up 29 basis points year-over-year and 7 basis points sequentially.
- Nonaccrual loans decreased 16%, net charge-offs were 17 basis points, and provision expense was $18 million.
- Noninterest expense was $209 million, slightly down from prior quarter, driving positive operating leverage.
- Noninterest income was $67 million, up 3% year-over-year and 14% sequentially.
- Reported earnings of $0.65 per share in Q2 2025.
- Return on tangible common equity (ROATCE) improved to 12.96%, up 62 basis points from Q1.
- Total loans grew 1% quarter-over-quarter and 3% year-over-year, or nearly 6% adjusted for loan sale.
- Adjusted consolidated net operating income was $84.1 million or $1.30 per diluted share.
- Commercial Auto segment had an underlying combined ratio of 90% with 18% PIF growth, despite $19 million adverse prior-year development.
- Kemper reported net income of $72.6 million or $1.12 per diluted share for Q2 2025.
- Life segment showed stable operating results with strong return on capital and distributable cash flows.
- Operating cash flow hit an all-time high of nearly $600 million trailing 12 months.
- Return on adjusted equity was 14.9%, with adjusted book value per share growth of 14.3% year-over-year.
- Specialty Auto segment produced an underlying combined ratio of 93.5% and 8% year-over-year policies in force (PIF) growth.
- The company repurchased $80 million of common stock since April 1 and received board approval for an additional $500 million repurchase authorization.
- Bankers Healthcare Group (BHG) had a strong quarter with fee revenues over $26 million and earnings growth guidance raised from 20% to approximately 40% for 2025.
- Deposit growth was 4.7% linked quarter annualized, slightly below initial expectations but expected to improve in the second half of the year.
- In 2Q 2025, Pinnacle Financial Partners reported revenue growth of 15.1% year-over-year, adjusted EPS growth of 22.7%, and tangible book value per share growth of 10.9%.
- Loans increased by 10.7% linked quarter annualized, exceeding initial expectations, with loan yield at 6.39%.
- Net charge-offs increased to 20 basis points from 16 basis points in the prior quarter, with reserves decreasing 2 basis points.
- Net interest income grew over 16% linked quarter annualized, with net interest margin (NIM) finishing at 3.23%, up 2 basis points from prior quarter.
- Asset quality remained stable with criticized loans declining $118 million, though other real estate owned increased by $167 million due to repossession of office properties.
- Capital ratios remained strong with CET1 at 11.2% and adjusted capital ratio at 11%, above peer median.
- Efficiency ratio improved to 52% from 56% in Q1, reflecting positive operating leverage.
- Net interest income grew 7.2% quarter-over-quarter to nearly $700 million, with net interest margin rising 6 basis points to 3.53%.
- Noninterest expense rose 3% to $515 million, mainly due to seasonal deposit cost increases.
- Noninterest income increased 16.4% to $148 million, driven by mortgage banking revenue of approximately $78 million.
- Provision expense was $40 million, reflecting organic loan growth and net charge-offs of approximately $30 million.
- Tangible book value per share increased 15% year-over-year to $55.87, with return on average tangible common equity at 14.9% and return on average assets at 1.1%.
- Western Alliance delivered strong Q2 2025 results, exceeding expectations with over $1 billion sequential loan growth and nearly $2 billion deposit growth.
- Brighthouse Financial reported second quarter 2025 adjusted earnings of $198 million or $3.43 per share, down from $245 million in Q1 2025 and $346 million in Q2 2024.
- Corporate expenses were $202 million pretax, down from $239 million in Q1 2025 but slightly higher than $200 million in Q2 2024.
- Estimated combined risk-based capital (RBC) ratio was between 405% and 425%, within the target range of 400% to 450%.
- Holding company liquid assets exceeded $900 million as of June 30, 2025.
- Life insurance sales reached $33 million in Q2, contributing to a record $69 million year-to-date, up 21% year-over-year.
- Total annuity sales increased 16% sequentially to $2.6 billion, with Shield sales contributing $1.9 billion and fixed annuities $500 million.
- 1.28 million shares were repurchased in Q2 at an average price of $17.30.
- Allowance for credit losses was $78 million or 0.93% of gross loans, slightly down from Q1.
- Net charge-offs were $249,000 in Q2 compared to net recoveries in Q1; classified loans decreased to $73.42 million.
- Net earnings for Q2 2025 were $50.6 million or $0.36 per share, consistent with prior quarters, marking 193 consecutive quarters of profitability.
- Net interest income increased by $1.2 million from Q1 2025 to $111.6 million, with net interest margin stable at 3.31%.
- Noninterest expense decreased by $1.6 million to $57 million, improving the efficiency ratio to 45.6%.
- Noninterest income was $14.7 million, down $1.5 million from Q1 2025 due to absence of a $2.2 million gain on OREO sales.
- Return on average tangible common equity was 14.08% and return on average assets was 1.34%.
- Shareholders' equity increased by $11 million to $2.24 billion; tangible common equity ratio remained at 10%.
- Total deposits and customer repurchase agreements grew to $12.4 billion, up $123 million from Q1 2025 and $330 million year-over-year.
- Total loans declined slightly to $8.36 billion, with growth in commercial real estate and single-family loans offset by declines in C&I and dairy and livestock lines.
- Hippo achieved positive net income from operating activities for the first time, with Q2 net income of $1 million and adjusted net income of $17 million, reflecting a $41 million and $37 million improvement respectively compared to Q2 2024.
- Hippo reported gross written premium growth of 16% year-over-year to $299 million in Q2 2025, driven by organic growth and new hybrid fronting programs.
- Operating expenses decreased by 16% year-over-year, falling from 46% to 30% of revenue, demonstrating improved operating leverage.
- Revenue increased 31% year-over-year to $117 million, supported by a 12% growth in gross earned premium and a 9 percentage point increase in premium retention to 39%.
- The consolidated net loss ratio improved significantly by 46 percentage points year-over-year to 47%, aided by underwriting actions, claims improvements, and favorable reserve developments.
- Aflac Japan saw a 23.2% year-over-year sales increase, driven by a 53% increase in cancer insurance sales, particularly from the Miraito product.
- Aflac reported adjusted earnings per diluted share of $1.78 for Q2 2025, a 2.7% decrease year-over-year, with a $0.04 positive FX impact.
- Aflac U.S. net earned premium increased 3.4%, with premium persistency rising to 79.2%.
- Capital deployment included $829 million in share repurchases and $312 million in dividends, totaling $1.1 billion returned to shareholders.
- Expense ratios improved in both Japan and U.S., with Japan's expense ratio at 20.6% and U.S. at 36.3%.
- Japan's total benefit ratio improved by 40 basis points to 66.5%, and persistency increased to 93.7%.
- Net earned premiums declined 4.8% in Japan but underlying earned premiums declined only 1.1%, indicating improving long-term premium trends.
- Net earnings per diluted share were $1.11, reflecting solid results for the quarter and a strong first half of the year.
- Strong capital ratios were maintained with SMR above 900%, regulatory ESR above 240%, and combined RBC greater than 600%.
- U.S. total benefit ratio was 47.3%, slightly higher by 60 basis points due to business mix, with a pretax margin of 22.5%.
Dafinchi